Table 4. Protection of rabbits against challenge with rHEV-3.
Groups (No.) | HEV 239 (μg) | Pre-challenge | Post challenge | |||
---|---|---|---|---|---|---|
Mean anti-HEV level ± SD(U/mL) | Number of rabbits shedding virus in fecesa | Ab resp.b | Number of rabbits with adverse pregnancy outcomesc | P valuesf | ||
E (6) | 2×10 | 389.2 ± 112.3 | 0/6 | − | 0/6 | 0.002* |
F (6) | 2×5 | 339.5 ± 165.2 | 0/6 | − | 1/6d | 0.015* |
G (6) | 2×0 | <1 | 6/6 | + (>4fold) | 6/6e | − |
aNumber of rabbits shedding virus in feces/total number of rabbits in the group.
bAb resp. (+) represents the mean anti-HEV level in every group post challenge is four times higher than that pre-challenge.
cNumber of rabbits with adverse pregnancy outcomes/total number of rabbits in the group.
dOne rabbit had stillbirth.
eOne rabbit died, three rabbits had stillbirth and two rabbits had miscarriage.
fThe vaccine efficacy compared to group G.
*Significantly different, P < 0.05.